Treatment of Mouse Bladder Tumor with LPS
Author Information
Author(s): Nativ, Medalia, Mor, Shajrawi, Sabo, Aronson
Primary Institution: Bnai Zion Medical Center, Haifa, Israel; Sackler School of Medicine, Tel Aviv, Israel; Sheba Medical Center, Tel Hashomer, Israel
Hypothesis
Can intravesical administration of LPS effectively treat experimental bladder tumors in mice?
Conclusion
Intravesical instillation of LPS significantly reduces the growth rate of implanted bladder tumors in mice.
Supporting Evidence
- LPS treatment started 3 days after tumor implantation significantly reduced tumor growth in T5 variant mice.
- T50 variant tumors did not respond to LPS when treatment was started 3 days after implantation but did respond when started 1-2 days after.
- Over 90% of shed cells were of tumoral origin, indicating effective targeting of the tumor.
Takeaway
This study found that a substance called LPS can help slow down the growth of bladder tumors in mice when given early after the tumors start to grow.
Methodology
The study involved administering LPS to two variants of mouse bladder tumors and measuring the effects on tumor growth.
Limitations
The experimental model showed variability in tumor progression rates, which affected reproducibility.
Participant Demographics
Inbred 8-10-week-old female C3H/eb mice were used in the study.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website